Company intelligence / Profile preview

Yusongyuan Pharmaceutical

Ownership: Private
Development stage: Other

Overview

Yusongyuan Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturer established in 2003, specializing in the production of chemical raw materials. The company has developed and optimized formulations for glucosamine hydrochloride gels, including establishing quality standards and demonstrating stable product performance. Clinical results or large-scale clinical trial outcomes are not publicly detailed, but the product appears to be at a commercial stage with published research on formulation optimization and quality control.

Therapeutic areas: Rheumatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Yusongyuan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yusongyuan Pharmaceutical.

Explore the full profile